Literature DB >> 17413641

Persistent periorbital and facial lymphedema associated with Group A beta-hemolytic streptococcal infection (erysipelas).

Golden T Buckland1, J Andrew Carlson, Dale R Meyer.   

Abstract

Chronic lymphedema is both a risk factor for and consequence of erysipelas (cellulitis). We report a case of a 62-year-old woman with rheumatoid arthritis treated with etanercept and prednisone, who developed chronic periorbital lymphedema 2 months after Group A beta-hemolytic streptococcus infection of the face. She had significant ptosis OS and thickened, hyperpigmented periorbital skin. Biopsies were consistent with chronic lymphedema. Of note, on 6 months follow-up, the patient's appearance was improved though she still had residual ptosis. A period of extended observation may be warranted in these cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413641     DOI: 10.1097/01.iop.0000256161.79015.38

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

1.  Lymphoedema: a paradoxical effect of tumour necrosis factor inhibitors - case report and review of literature.

Authors:  Hajra Ismail Tily; Andras Perl
Journal:  BMJ Case Rep       Date:  2009-03-05

2.  Fatal group A Streptococcus purpura fulminans in a child receiving TNF-α blocker.

Authors:  Christian Renaud; Philippe Ovetchkine; Patricia Bortolozzi; Claire Saint-Cyr; Bruce Tapiero
Journal:  Eur J Pediatr       Date:  2010-11-10       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.